Basic Concepts in Molecular Medicine (Molecular and Translational Medicine)

個数:
  • ポイントキャンペーン

Basic Concepts in Molecular Medicine (Molecular and Translational Medicine)

  • ウェブストア価格 ¥41,835(本体¥38,032)
  • Humana Pr Inc(2013/08発売)
  • 外貨定価 UK£ 138.00
  • 【ウェブストア限定】洋書・洋古書ポイント5倍対象商品(~2/28)
  • ポイント 1,900pt
  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版
  • 言語 ENG
  • 商品コード 9781603275002
  • DDC分類 616

Full Description


Volume 1 begins with an introduction covering the concepts of molecular medicine and personalized medicine. Subsequent chapters cover the topics of genomics, transcriptomics, epigenomics, and proteomics, as the tools of molecular pathology and foundations of molecular medicine. These chapters are followed by a series of chapters that provide overviews of molecular medicine as applied broadly to neoplastic, genetic, and infectious diseases, as well as a chapter on molecular diagnostics (how we harness diagnostic clues to guide treatment). The volume concludes with a chapter that delves into the promise of molecular medicine in the personalized treatment of patients with complex diseases, along with a discussion of the challenges and obstacles to personalized patient care.

Contents

Chapter 1; Molecular MedicineM.D., Ph.D. Center for Genome Science, Duke University School of Medicine, Durham, NC; Chapter 2; Genomic Classification of Disease; David P. Carbone, M.D., Ph.D. Division of Hematology/Oncology, Department of Medicine, Vanderbilt-Ingram Comprehensive Cancer Center, Vanderbilt University School of Medicine, Nashville, TN; Chapter 3; Transcriptomic Classification of Disease; Matt van de Rijn, M.D., Ph.D. Department of Pathology, Stanford University School of Medicine, Stanford, CA; Chapter 4; Epigenomic Classification of Disease; Peter A. Jones, Ph.D. Departments of Urology, Biochemistry, and Molecular Biology, University of Southern California/Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA; Chapter 5; Proteomic Classification of Disease; Lance Liotta, Ph.D. The Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA; Chapter 6; Molecular Medicine in Neoplastic Disease; Gavin J. Gordon, Ph.D. Department of Surgery Research, Dana Farber/Harvard Medical Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Chapter 7; Molecular Medicine in Genetic Disease; Markus Grompe, M.D. Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, OR; Chapter 8; Molecular Medicine in Infectious Disease; Michael G. Bergeron, Ph.D. Research Center in Infectious Diseases, Centre Hospitalier Universitaire de Quebec, Quebec City, Quebec, Canada; Chapter 9; Molecular Diagnostics: Harnessing the Clues to Direct the Treatment of Human Disease; William B. Coleman, Ph.D., and Gregory J. Tsongalis, Ph.D. Department of Pathology and Laboratory Medicine, UNC Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC, and Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH; Chapter 10; Personalized Treatment of Complex Diseases: The Promise of Molecular Medicine; Leroy E. Hood, M.D., Ph.D. Institute for Systems Biology, Department of Molecular and Cellular Biology, University of Washington, Seattle, WA

最近チェックした商品